Use of BPaL to treat RR/MDR-TB, pre-XDR-TB, and extensive disease: real-world outcomes from a cohort in Germany
The International Journal of Tuberculosis and Lung Disease · 01.06.2026 · 30 (6) · 291-293
DOI: 10.5588/ijtld.25.0650 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, erschienen am 01.06.2026. Verfasst von J Trauth und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine V, Internal Medicine, Infectious Diseases and Infection Control, Justus-Liebig-University Giessen, Member of the German Center….
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine V, Internal Medicine, Infectious Diseases and Infection Control, Justus-Liebig-University Giessen, Member of the German Center for Lung Research (DZL), The Institute for Lung Health (ILH), Member…
- National and WHO Supranational Reference Laboratory for Tuberculosis, Research Center Borstel, Borstel, Germany.
Zitieren
APA
Trauth, J., Kohlhaas, J., Dreyer, V., Kuhns, M., Friesen, I., & Herold, S. (2026). Use of BPaL to treat RR/MDR-TB, pre-XDR-TB, and extensive disease: real-world outcomes from a cohort in Germany. The International Journal of Tuberculosis and Lung Disease, 30(6), 291-293. https://doi.org/10.5588/ijtld.25.0650
Vancouver
Trauth J, Kohlhaas J, Dreyer V, Kuhns M, Friesen I, Herold S. Use of BPaL to treat RR/MDR-TB, pre-XDR-TB, and extensive disease: real-world outcomes from a cohort in Germany. The International Journal of Tuberculosis and Lung Disease. 2026;30(6):291-293. doi:10.5588/ijtld.25.0650
BibTeX
@article{Trauth2026,
author = {Trauth, J and Kohlhaas, J and Dreyer, V and Kuhns, M and Friesen, I and Herold, S},
title = {Use of BPaL to treat RR/MDR-TB, pre-XDR-TB, and extensive disease: real-world outcomes from a cohort in Germany},
journal = {The International Journal of Tuberculosis and Lung Disease},
year = {2026},
volume = {30},
number = {6},
pages = {291--293},
doi = {10.5588/ijtld.25.0650}
}
EUVIMED